Meta-analysis of pramipexole in treatment of restless legs syndrome
- Author:
- No author available
- Journal Title:
- Chinese Journal of Neurology
- Issue:
- 3
- DOI:
- 10.3760/cma.j.issn.1006-7876.2012.03.010
- Key Word:
- 不宁腿综合征;苯并噻唑类;Meta分析;Restless legs syndrome;Benzothiazoles;Meta-analysis
Abstract： Objective To evaluate the efficacy and safety of pramipexole in treating restless legs syndrome (RLS).Methods A search for randomized,double-blind,and placebo-controlled clinical trials of pramipexole in treating moderate to severe RLS using CNKI,PubMed,Embase and Cochrane Library database was carried out. A meta-analysis of included clinical trials was performed with RevMan 5.0 software.The 2 outcomes that the weighted mean difference(WMD) of change from baseline in International RLS Study Group rating scale(IRLS) score and the relative risk (RR) of response based on the Clinical Global Impression-Improvement (CGI-I) scale score were calculated for efficacy.Safety was assessed with RR of the adverse event (AE).Results A total of 5 clinical trials were included in this meta-analysis,of which 1776 patients were randomly assigned (945 on pramipexole,831 on placebo).The records of patients were pooled.Overall WMD were - 6.34 ( Z =12.76,P ＜ 0.01 ) for the change from baseline in IRLS score,and RR of response based on CGI-I were 1.65 (Z =10.39,P ＜0.01).The overall RR of pramipexole versus placebo were 1.14 ( Z =1.87,P =0.06 ) for AE.Conclusion To treat RLS,pramipexole is an effective and safe drug.
- [1]中华医学会神经病学分会帕金森病及运动障碍学组.不宁腿综合征的诊断标准和治疗指南[J].2009,(10).
- [2]史洁,耿同超.不安腿综合征[J].2006,(7).
- [3]Montagna P,Hornyak M,Ulfberg J,etc.Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood.[J].2011,12(1).
- [4]Partinen M,Jama L,Hirvonen K.A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.[J].2009,10(6).
- [5]Becker PM,Koester J,Reess J,etc.Efficacy and safety of pramipexole in restless legs syndrome.[J].2006,67(6).
- [6]Stiasny-Kolster K,Hallstrom Y,Schindler T,etc.Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).[J].2007,22(2).
- [7]Alakuijala A,Koester J,Reess J,etc.Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study-The PRELUDE study.[J].2006,7(5).
- [8]Stiasny Kolster K,Oertel WH,Koester J,etc.Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.[J].2006,21(9).
- [9]Kitsios GD,Papathanasiou A,Zintzaras E.Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis.[J].2010,32(2).
- [10]主编刘鸣.系统评价、Meta-分析设计与实施方法[M].2011.
- [11]Saletu M,Seppi K,Rungger G,etc.Restless legs syndrome: a community-based study of prevalence, severity, and risk factors.[J].2005,64(11).
- [12]Partinen M,Sohr M,Aarskog D,etc.Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.[J].2008,9(8).
- [13]Tison F,Leger D,Lainey E,etc.Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study.[J].2005,65(2).
- [14]Kuroda,Inoue Y,Hirata K.Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.[J].2010,11(1).
- [15]Schapira AH.Restless legs syndrome: an update on treatment options.[J].2004,64(2).
- [16]Walters AS,Allen RP,Rosen R,etc.Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome.[J].2003,4(2).
- [17]Martin M,Lleu PL,Nicolas A,etc.Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.[J].2008,9(7).
- [18]Shimizu T,Uchimura N,Hirata K,etc.Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trial.[J].2011,63(1).
- [19]Hening WA,Trenkwalder C,Montplaisi J,etc.Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.[J].2003,4(2).